article thumbnail

Midlife Blood Biomarkers Predict Late-Life Dementia

Med Page Today

(MedPage Today) -- PHILADELPHIA -- Blood biomarkers specific to Alzheimer's disease -- specifically, amyloid-beta 42/40 ratios and measures of phosphorylated tau 181 (p-tau181) -- had a relationship with subsequent dementia that started in.

article thumbnail

Alzheimer's Biomarkers Show Tantalizing Hint at Utility for Tracking Prevention

Med Page Today

(MedPage Today) -- PHILADELPHIA -- Blood tests for Alzheimer's disease biomarkers may not only be useful for clinical diagnosis but could also make it possible to test preventive therapies in people not yet showing any signs of the condition.

article thumbnail

Heart transplantation and biomarkers: a review about their usefulness in clinical practice

Frontiers in Cardiovascular Medicine

As a result, numerous biomarkers have been investigated in an effort to identify and prevent certain diseases sooner. These biomarkers are typically linked to complications from HTX. We also highlight the relationships between each biomarker and one or more problems, as well as their applicability in routine clinical practice.

article thumbnail

Biomarkers in COPD

HCPLive

Igor Barjaktarevic, MD, PhD, provides insights on the evolving role of biomarkers in COPD, highlighting the role of eosinophils on informing treatment decisions.

article thumbnail

Urinary Inflammatory Biomarkers Show Prognostic Value for IgA Nephropathy

HCPLive

Urinary cytokines GDF-15, IL-6, and EGF significantly strengthened the predictability of IgAN prognosis and may be viable biomarker candidates for disease progression.

article thumbnail

Study Highlights Top 5 Inflammatory Biomarkers, Relationship with Atopic Dermatitis Severity

HCPLive

These data on systemic inflammatory biomarkers for patients with eczema may allow for more targeted treatments and for greater personalization of medicine for this skin condition.

article thumbnail

HF Risk Assessment Using Biomarkers in Patients With AF

American College of Cardiology

What is the value of specific biomarkers for heart failure (HF) risk stratification in patients with atrial fibrillation (AF)?